BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

523 related articles for article (PubMed ID: 28526896)

  • 41. Age, But Not Repeated Exposure to Gadoterate Meglumine, Is Associated With T1- and T2-Weighted Signal Intensity Changes in the Deep Brain Nuclei of Pediatric Patients.
    Pozeg P; Forget J; Meuli RA; Maeder P
    Invest Radiol; 2019 Sep; 54(9):537-548. PubMed ID: 30973458
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Intravenous injection of gadobutrol in an epidemiological study group did not lead to a difference in relative signal intensities of certain brain structures after 5 years.
    Kromrey ML; Liedtke KR; Ittermann T; Langner S; Kirsch M; Weitschies W; Kühn JP
    Eur Radiol; 2017 Feb; 27(2):772-777. PubMed ID: 27221561
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evaluation of 3.0-T MRI Brain Signal after Exposure to Gadoterate Meglumine in Women with High Breast Cancer Risk and Screening Breast MRI.
    Bennani-Baiti B; Krug B; Giese D; Hellmich M; Bartsch S; Helbich TH; Baltzer PAT
    Radiology; 2019 Dec; 293(3):523-530. PubMed ID: 31638488
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Gadolinium deposition in the brain: association with various GBCAs using a generalized additive model.
    Bae S; Lee HJ; Han K; Park YW; Choi YS; Ahn SS; Kim J; Lee SK
    Eur Radiol; 2017 Aug; 27(8):3353-3361. PubMed ID: 28083696
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of Age on High T1 Signal Intensity of the Dentate Nucleus and Globus Pallidus in a Large Population Exposed to Gadodiamide.
    Quattrocchi CC; Errante Y; Mallio CA; Marinelli L; LoVullo G; Giannotti G; Della Sala SW; van der Molen AJ; Beomonte Zobel B
    Invest Radiol; 2018 Apr; 53(4):214-222. PubMed ID: 29166300
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Changes in Signal Intensity of the Dentate Nucleus and Globus Pallidus in Pediatric Patients: Impact of Brain Irradiation and Presence of Primary Brain Tumors Independent of Linear Gadolinium-based Contrast Agent Administration.
    Tamrazi B; Nguyen B; Liu CJ; Azen CG; Nelson MB; Dhall G; Nelson MD
    Radiology; 2018 May; 287(2):452-460. PubMed ID: 29189102
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Dentate Nucleus Signal Intensity Decrease on T1-weighted MR Images after Switching from Gadopentetate Dimeglumine to Gadobutrol.
    Behzadi AH; Farooq Z; Zhao Y; Shih G; Prince MR
    Radiology; 2018 Jun; 287(3):816-823. PubMed ID: 29533723
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Higher magnetic susceptibility of globus pallidus in patients after macrocyclic GBCAs: assessment using quantitative susceptibility mapping.
    Zhang J; Xie L; Yang X; Xu L; Chen K; Luo Y; Yu C
    Acta Radiol; 2023 Jul; 64(7):2261-2267. PubMed ID: 36567675
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evaluation of signal intensity changes in dentate nucleus and globus pallidus on magnetic resonance imaging after intrathecal gadolinium-based contrast agent administration.
    Asoğlu S; Kılınçer A; Özer H; Topaloğlu ÖF; Cebeci H
    Clin Imaging; 2024 May; 109():110140. PubMed ID: 38574605
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Gadolinium deposition within the dentate nucleus and globus pallidus after repeated administrations of gadolinium-based contrast agents-current status.
    Stojanov D; Aracki-Trenkic A; Benedeto-Stojanov D
    Neuroradiology; 2016 May; 58(5):433-41. PubMed ID: 26873830
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Retention of Gadolinium-Based Contrast Agents in Multiple Sclerosis: Retrospective Analysis of an 18-Year Longitudinal Study.
    Forslin Y; Shams S; Hashim F; Aspelin P; Bergendal G; Martola J; Fredrikson S; Kristoffersen-Wiberg M; Granberg T
    AJNR Am J Neuroradiol; 2017 Jul; 38(7):1311-1316. PubMed ID: 28495943
    [TBL] [Abstract][Full Text] [Related]  

  • 52. High signal intensity in dentate nucleus and globus pallidus on unenhanced T1-weighted MR images in three patients with impaired renal function and vascular calcification.
    Barbieri S; Schroeder C; Froehlich JM; Pasch A; Thoeny HC
    Contrast Media Mol Imaging; 2016 May; 11(3):245-50. PubMed ID: 26929131
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Dentate nucleus signal intensity changes on T1-weighted MRI after repeated administrations of linear and macrocyclic gadolinium-based contrast agents: a pediatric intraindividual case-control study.
    Ozturk K; Nascene D
    Acta Radiol; 2022 Jul; 63(7):914-922. PubMed ID: 34018821
    [TBL] [Abstract][Full Text] [Related]  

  • 54. T1 Signal Measurements in Pediatric Brain: Findings after Multiple Exposures to Gadobenate Dimeglumine for Imaging of Nonneurologic Disease.
    Schneider GK; Stroeder J; Roditi G; Colosimo C; Armstrong P; Martucci M; Buecker A; Raczeck P
    AJNR Am J Neuroradiol; 2017 Sep; 38(9):1799-1806. PubMed ID: 28642266
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Diffusion-weighted imaging of the dentate nucleus after repeated application of gadolinium-based contrast agents in multiple sclerosis.
    Eisele P; Szabo K; Ebert A; Radbruch A; Platten M; Schoenberg SO; Gass A
    Magn Reson Imaging; 2019 May; 58():1-5. PubMed ID: 30630068
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Increased Signal Intensity in the Dentate Nucleus on Unenhanced T1-Weighted Images After Gadobenate Dimeglumine Administration.
    Weberling LD; Kieslich PJ; Kickingereder P; Wick W; Bendszus M; Schlemmer HP; Radbruch A
    Invest Radiol; 2015 Nov; 50(11):743-8. PubMed ID: 26352749
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Contrast Agent-Induced High Signal Intensity in Dentate Nucleus on Unenhanced T1-Weighted Images: Comparison of Gadodiamide and Gadoxetic Acid.
    Ichikawa S; Motosugi U; Omiya Y; Onishi H
    Invest Radiol; 2017 Jul; 52(7):389-395. PubMed ID: 28195932
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Signal intensity increases in dentate nucleus/globus pallidus/pulvinar on unenhanced T1WI MR images after multiple examinations with gadodiamide.
    Koiso T; Yamamoto M; Watanabe S; Barfod BE
    Neuroradiol J; 2019 Jun; 32(3):215-224. PubMed ID: 30924388
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Does Gadoterate Meglumine Cause Gadolinium Retention in the Brain of Children? A Case-Control Study.
    Topcuoglu ED; Topcuoglu OM; Semiz Oysu A; Bukte Y
    J Magn Reson Imaging; 2020 May; 51(5):1471-1477. PubMed ID: 31665554
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Gadolinium Deposition within the Pediatric Brain: No Increased Intrinsic T1-Weighted Signal Intensity within the Dentate Nucleus following the Administration of a Minimum of 4 Doses of the Macrocyclic Agent Gadoteridol.
    Young JR; Pope WB; Bobinski M
    AJNR Am J Neuroradiol; 2018 Sep; 39(9):1604-1608. PubMed ID: 30093477
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.